COMMENT: This study showed that the utilization of the IV tranexamic acid (TXA) protocol significantly decreased takebacks to the operative room for post-operative tonsillar bleeds. Though the number of children that require re-cauterization for tonsil bleeds can be low, the use of TXA in this protocol reduced this number to a relative risk of 0.59 with no adverse events. It also equates to significant cost savings, avoiding the OR for re-bleeds of the tonsillar fossa.—Ryan Belcher, MD, MPH
Leave a Reply